Fresolimumab and Radiotherapy in Metastatic Breast Cancer.

Trial Profile

Fresolimumab and Radiotherapy in Metastatic Breast Cancer.

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 19 Mar 2018

At a glance

  • Drugs Fresolimumab (Primary)
  • Indications Advanced breast cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 14 Mar 2018 Planned End Date changed from 1 Jun 2017 to 1 Jun 2019.
    • 23 Feb 2018 Results published in the Clinical cancer research: an official journal of the American Association for Cancer Research
    • 21 Feb 2017 Planned End Date changed from 1 Mar 2016 to 1 Jun 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top